AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 188 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $446,457 | -2.5% | 6,388 | +0.2% | 0.00% | 0.0% |
| Q2 2023 | $458,107 | +10.1% | 6,375 | -5.5% | 0.00% | 0.0% |
| Q1 2023 | $416,093 | -41.5% | 6,746 | -26.8% | 0.00% | 0.0% |
| Q4 2022 | $710,753 | +72.9% | 9,215 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $411,000 | -37.0% | 9,221 | -4.6% | 0.00% | 0.0% |
| Q2 2021 | $652,000 | +7.4% | 9,668 | -9.8% | 0.00% | 0.0% |
| Q1 2021 | $607,000 | -33.0% | 10,721 | -3.6% | 0.00% | -50.0% |
| Q4 2020 | $906,000 | +7.1% | 11,121 | -6.3% | 0.00% | 0.0% |
| Q3 2020 | $846,000 | -43.0% | 11,875 | -34.2% | 0.00% | -50.0% |
| Q2 2020 | $1,485,000 | +142.3% | 18,050 | +73.1% | 0.00% | +100.0% |
| Q1 2020 | $613,000 | -58.6% | 10,426 | -27.2% | 0.00% | -50.0% |
| Q4 2019 | $1,479,000 | – | 14,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |